Amphion Innovations PLC Issue of Shares (3582Y)
05 December 2017 - 6:00PM
UK Regulatory
TIDMAMP
RNS Number : 3582Y
Amphion Innovations PLC
05 December 2017
AMPHION INNOVATIONS PLC
("Amphion" or "the Company")
Share Issuance
London and New York, Amphion Innovations plc (AIM: AMP), the
developer of medical, life science, and technology businesses,
today announces that the Company has issued 1,664,659 ordinary
shares, representing 0.80% of the enlarged issued share capital, to
a holder ("Note Holder") of the Convertible Promissory Notes
December 2008 - December 2017 (the "CPN"). The Note Holder is
converting its CPN Holding of GBP133,172.76 into Amphion ordinary
shares at 8 pence per share.
An application has been made for the new ordinary shares to be
admitted to trading on AIM. Admission of the 1,664,659 new ordinary
shares, ranking pari passu with the existing ordinary shares, is
expected on 8 December 2017. Following this allotment, the total
issued share capital of the Company will be 209,175,888 ordinary
shares with each ordinary share holding one voting right. This
figure may be used by shareholders in the Company as the
denominator for the calculation by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the share capital of the Company under the Financial
Conduct Authority's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014 ("MAR").
For further information please contact:
Amphion Innovations Tel: +1 (212) 210 6224
Charlie Morgan
Panmure Gordon Limited (Nominated Tel: +44 (0)20
Adviser and Corporate Broker) 7886 2500
Freddy Crossley / Ryan McCarthy
(Corporate Finance)
Charlie Leigh-Pemberton
(Corporate Broking)
Northland Capital Partners Tel: +44 (0)20 3861
Limited (Joint Corporate Broker) 6625
Patrick Claridge / David
Hignell (Corporate Finance)
John Howes (Corporate
Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
or
Mike Wort/ Paul McManus amphion@walbrookpr.com
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and
technology businesses. We use our extensive experience in company
building to invest and build shareholder value in high growth
companies in the US and UK. Amphion has significant shareholding in
a small number of Partner Companies developing proven technologies
targeting substantial commercial marketplaces. The Amphion model
has been refined to optimise the commercialisation of patents and
other intellectual property within the Partner Companies.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOELFFFIFDLSIID
(END) Dow Jones Newswires
December 05, 2017 02:00 ET (07:00 GMT)
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2024 to May 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From May 2023 to May 2024